Minami H, Kiyota N, Omori T. Did the Randomized Phase III KEYNOTE-181 Study of Pembrolizumab for Esophageal Cancer Yield Negative or Positive Results? J Clin Oncol 2021 Apr 12:JCO2003262. doi: 10.1200/JCO.20.03262.
PMID: 33844589